Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer.
BACKGROUND: Breast cancer (BC) continues to be a major health concern with 250,000 new cases diagnosed annually in the USA, 75% of which are hormone receptor positive (HR+), exp...